JJ van Oosterhout

Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation

H K Nieuwenhuis, JJ van Oosterhout, E Rozemuller et al. · Blood · 1987 · 282 citations · Full text

Medicine, Biochemistry, Cell Biology +13

Second‐line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline^*

MC Hosseinipour, JJ Kumwenda, Ralf Weigel et al. · HIV Medicine · 2010 · 91 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation

H K Nieuwenhuis, JJ van Oosterhout, E Rozemuller et al. · Blood · 1987 · 17 citations · Full text

Medicine, Biochemistry, Cell Biology +13

Post exposure prophylaxis of HIV transmission after occupational injuries in Queen Elizabeth Central Hospital, Blantyre, Malawi, 2003 – 2008

GC Van der Maaten, Mulinda Nyirenda, M B J Beadsworth et al. · Malawi Medical Journal · 2010 · 14 citations · Full text

Public Health, Injury Prevention, Preventive Medicine +17

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

Cissy Kityo, David Dunn, Anne Hoppé et al. · Clinical Infectious Diseases · 2018 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17